Pelage Christina Weng
other
About
Qing Yu Christina Weng, also cited publicly as Christina Weng, M.D., is the Chief Medical Officer of Pelage Pharmaceuticals, a clinical-stage regenerative medicine company developing PP405 for androgenetic alopecia. Public reporting shows her as a medical spokesperson for Pelage’s Phase 2a results and the company’s broader regenerative-medicine ambitions around dormant stem-cell reactivation.
Areas of interest
regenerative medicinedermatologyalopeciahair loss therapeuticsstem cell biologyaging